Stockscreener 앱 받기
1.38
4.55%
0.06
시간 외 거래:
1.40
0.02
+1.45%
전일 마감가:
$1.32
열려 있는:
$1.32
하루 거래량:
430.03K
Relative Volume:
0.85
시가총액:
$191.45M
수익:
$108.81M
순이익/손실:
$-186.70M
주가수익비율:
-1.639
EPS:
-0.842
순현금흐름:
$-16.83M
1주 성능:
+4.55%
1개월 성능:
+5.34%
6개월 성능:
-16.87%
1년 성능:
-7.38%
1일 변동 폭
$1.32
$1.39
1주일 범위
$1.31
$1.40
52주 변동 폭
$0.85
$2.08
Organigram Global Inc Stock (OGI) Company Profile
명칭
Organigram Global Inc
전화
-
주소
-
OGI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.38 | 191.45M | 108.81M | -186.70M | -16.83M | -0.842 |
|
RGC
Regencell Bioscience Holdings Ltd
|
10.36 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.08 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.26 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-17 | 재개 | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-12 | 업그레이드 | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | 업그레이드 | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | 다운그레이드 | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | 다운그레이드 | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | 개시 | Alliance Global Partners | Buy |
| 2020-01-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | 개시 | BofA/Merrill | Underperform |
| 2020-01-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-11 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Organigram Global Inc 주식(OGI)의 최신 뉴스
Hemp, Hope And Hard Truths: A New Era Of Realism At Benzinga's Chicago Summit - Benzinga
Organigram (TSE:OGI) Stock Price Up 2% – Should You Buy? - Defense World
Organigram Holdings Inc. (NASDAQ:OGI) Stock Position Decreased by Jane Street Group LLC - Defense World
Are Tobacco Companies Ready To Invest In Cannabis?Organigram Global (NASDAQ:OGI) - Benzinga
organigram global inc. files 6-k report with sec By Investing.com - Investing.com South Africa
organigram global inc. files 6-k report with sec - Investing.com India
Organigram Global Announces CEO Retirement and Succession Plan - TipRanks
THC Drinks Aren't The New Beer, They're Something Else, Says Tilray - Benzinga
Organigram CEO Beena Goldenberg to retire - MSN
How I Built Canada’s Biggest Cannabis Company - Canadian Business
Organigram CEO To Retire After Building Canada's Largest Cannabis Brand: Here's What's Next - Benzinga
Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting - Benzinga
Organigram begins process to find new CEO with Beena Goldenberg stepping down - StratCann
Beena Goldberg to Retire as Organigram Global CEO - mg Magazine
Goldenberg retiring as CEO of cannabis producer Organigram - MJBizDaily
Organigram (OGI) CEO Beena Goldenberg Announces Retirement | OGI Stock News - GuruFocus
Organigram (OGI) CEO Beena Goldenberg to Retire in 2025 - GuruFocus
Organigram Global Announces CEO Succession Amidst Strong Growth - TipRanks
Organigram Global Announces CEO Succession Plan | OGI Stock News - GuruFocus
Organigram Brief: Announcing CEO Succession Plan;B eena Goldenberg, CEO to Retire At End of the Company's fiscal year - marketscreener.com
Organigram Global Announces CEO Succession Plan - The Globe and Mail
3 Reasons to Buy Realty Income Stock Like There's No Tomorrow - The Globe and Mail
Decibel Cannabis stock is a worthwhile purchase, Haywood says - Mugglehead Magazine
This Week In Cannabis: Earnings Season, Uruguay's 'Pepe' Mujica's Legacy, DEA's Meme Backlash, California's Tax Hike, The DEA's Stance And More - Benzinga
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands - Seeking Alpha
Buy Organigram for big returns, Haywood says - Cantech Letter
Organigram Reports Second Quarter Fiscal 2025 Results - mg Magazine
Organigram Global Inc. (NASDAQ:OGI) Q2 2025 Earnings Call Transcript - Insider Monkey
Organigram reports record Q2 fiscal 2025 results | 2025-05-12 | Investing News - Stockhouse
Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance
Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Re - GuruFocus
Organigram Global’s Earnings Call Highlights Growth and Market Leadership - TipRanks
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised) - Yahoo Finance
OrganiGram: Fiscal Q2 Earnings Snapshot - MySA
Organigram has sights set on global expansion after ‘record’ quarter - BNN Bloomberg
Organigram reports spike in sales, revenue from Motif acquisition - StratCann
Organigram Q2 2025 Earnings Call Transcript - MarketBeat
OrganiGram Q2 2025 presentation slides: record revenue, strategic acquisitions fuel growth - Investing.com India
Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% By Investing.com - Investing.com Nigeria
Organigram Lights Up Q2 With 74% Sales Surge, Profitable TurnOrganigram Global (NASDAQ:OGI) - Benzinga
Organigram reports record Q2 fiscal 2025 results - MSN
Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% - Investing.com
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Organigram Q2 Was Better Than Expected - New Cannabis Ventures
Organigram Reports Record Second Quarter Fiscal 2025 Results | O - GuruFocus
Organigram Global Inc (OGI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.01%
0.40%
자본화:
|
볼륨(24시간):